Biotronik Ag
Clinical trials sponsored by Biotronik Ag, explained in plain language.
-
Magnesium scaffolds under Real-World watch for heart disease
Disease control Recruiting nowThis registry follows over 1,100 people with coronary artery disease who receive resorbable magnesium scaffolds to open blocked arteries. The goal is to see how well these temporary scaffolds work and how safe they are in everyday medical practice. Researchers will track heart-re…
Sponsor: Biotronik AG • Aim: Disease control
Last updated May 17, 2026 11:50 UTC
-
Dissolvable stent could revolutionize heart disease treatment
Disease control Recruiting nowThis study tests a new type of heart stent that slowly dissolves over time. It is designed for people with long blockages in their coronary arteries. The goal is to see if the stent is safe and effective at keeping arteries open without needing a permanent metal implant.
Phase: NA • Sponsor: Biotronik AG • Aim: Disease control
Last updated May 17, 2026 11:36 UTC
-
Dissolvable heart stent could change artery treatment forever
Disease control Recruiting nowThis study tests a new type of heart stent made from magnesium that slowly dissolves over time, compared to a permanent metal stent. The goal is to see if the dissolvable stent is safe and works as well for people with blocked heart arteries. About 1,859 adults with coronary arte…
Phase: NA • Sponsor: Biotronik AG • Aim: Disease control
Last updated May 06, 2026 16:15 UTC